Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Percent.
The item "Operating-Return-On-Assets" stands at 3.84 percent as of 09/30/2025.
As of the end of Eisai Co. Ltd.'s second quarter, the item "Operating Return On Assets" stands at 3.84 Percent. This represents a decrease of -0.04 percentage points compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.4583 compared to the value the year prior.
The Serie's long term average value is 3.23 percent. It's latest available value, on 09/30/2025, is 0.607 higher, compared to it's long term average value.
The Serie's change from it's minimum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is +4.39 .
The Serie's change in percentage points from it's maximum value, on 09/30/2023, to it's latest available value, on 09/30/2025, is -1.30.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Operating Return On Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Operating Return On Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Operating Return On Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Operating Return On Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Operating Return On Assets | 280,205,508,085.11 |